Back to top

Pfizer Expands Migraine Strategy With New Rimegepant Redosing Study

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer tests migraine pill redosing in new phase 4 trial. The study, titled ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Pfizer Inc. (PFE)